Gerald Batist

Director

Dr. Gerald Batist is Deputy Director and Senior Investigator at the Lady Davis Institute and a Fellow of the Canadian Academy of Health Sciences. As an international leader in cancer therapy research, he is known for his innovative work in molecular oncology and precision medicine. He has generated leading edge experimental data on mechanisms of tumour resistance and strategies to overcome it. His laboratory and clinical research program has been credited with over 180 scientific publications. He has trained many scientists and clinical oncologists, and also practices medical oncology. Dr. Batist holds several additional directorships including Director of the McGill Centre for Translational Research in Cancer at the Lady Davis Institute, Director of the Segal Cancer Centre at Jewish General Hospital, Director of the Department of Oncology at Sir Mortimer B. Davis-Jewish General Hospital, and Scientific Director of the Montreal Centre for Experimental Therapeutics in Cancer. He helps lead the National Centre of Excellence in Personalized Medicine called Exactis. He is also a professor in the Department of Medicine and Minda de Gunzburg Professor of Oncology at McGill University. Dr. Batist founded the McGill Centre for Translational Research in Cancer, the research core of the Segal Cancer Centre at the Jewish General Hospital, which is focused on efficient translation of new research discoveries into clinical benefits for patients. He also created the Quebec Consortium for Clinical Research in Cancer (Q-CROC). Q-CROC operates as a network for oncology care and research, with a focus on biomarker-driven clinical trials and conducting serial biopsies of metastatic cancers that will define molecular signatures of therapeutic resistance to specific treatments.